Market Trends of Thawing System Industry
Blood Segment is Anticipated to Witness a Growth in the Market Over the Forecast Period
- The blood sample segment is poised to experience significant growth in the studied market due to several factors, including the rising incidence of hematological diseases, an increase in research studies, rapid technological advancements, and a greater awareness of the benefits of plasma therapy. For example, according to an article published in PubMed in November 2022, researchers demonstrated that plasma samples subjected to up to 10 freeze-thaw cycles with quick freezing and thawing exhibited remarkably stable metabolite levels. These results are expected to inform future workflows for preparing plasma samples for metabolomics analyses.
- Furthermore, an increase in hematological diseases and the need for plasma therapy are likely to boost market growth during the forecast period. Additionally, a high prevalence of blood donation and transfusion is contributing to segment growth. For instance, according to a 2022 update from the Health Sciences Authority (HSA) of Singapore, in 2021, the HSA collected 114.5 thousand whole blood and 9.5 thousand apheresis donations, while 69 thousand people donated blood in Singapore in 2021. As the number of blood donations increases, the donated blood stores in the blood bank, which in turn, drives demand for the segment during the forecast period.
- Moreover, the approval of products is also driving the growth of the market segment. For example, in July 2020, FreMon Scientific received clearance from the United States Food and Drug Administration (FDA) for ZipThaw, a Class II medical device for frozen plasma thawing. ZipThaw, when used with the ZipSleeve anti-contaminant disposable barrier, is one of the world's first dry and portable precision plasma thawing systems.
- Therefore, the combination of increased demand for blood thawing systems and rapid technological advancements is expected to drive significant growth in the studied segment during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America Anticipated to Hold a Significant Market Share Over the Forecast Period
- North America is anticipated to maintain a noteworthy market share throughout the forecast period due to several factors, such as the development of blood bank and biobank infrastructure, rising research activities in regenerative medicine, cell and gene therapy, increasing interest in customized medicine and biomarker discovery, and a growing number of biotechnology and pharmaceutical companies, as well as increasing government funding.
- For example, as per the estimates of the American National Red Cross in October 2021, around 36,000 units of red blood cells are required every day, and nearly 25 million blood components are transfused each year in the United States. Since thawed plasma is widely stored in blood banks to maintain its viability, the need for defrosting arises when necessary, and thawing systems are likely to be utilized more frequently, thereby fueling market growth during the forecast period.
- Moreover, an increase in strategic activities by key players and product launches is also expected to drive market growth. Thermo Fisher, for instance, launched Controlled-Rate Freezers in January 2021, providing optimal sample protection. CryoMed Freezers offer repeatable, consistent temperature performance, enhanced data traceability, and support GMP and 21 CFR Part 11 requirements.
- As a result of the rise in demand for thawing systems and the rapid advancement of technology, North America is expected to witness significant growth in the market during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
